Chronic Radiation Dermatitis Secondary to Narrow-Band Ultraviolet B Therapy in a Patient With Primary Cutaneous CD8+ T-Cell Lymphoma With Cytotoxic Granules Mia P. Edelson, Jane J. Gay, Robert W. Thiel, Douglas J. Grider The American Journal of Dermatopathology.2024;[Epub] CrossRef
Null T‐cell phenotype mycosis fungoides with aberrant CD20 and CD56 expression: A diagnostic dilemma Brenna M. Aran, Regina Burton, Whitney A. High, Alejandro A. Gru Journal of Cutaneous Pathology.2024; 51(8): 614. CrossRef
Primary cutaneous CD8+ cytotoxic T‐cell lymphoma of the face with intraoral involvement, resulting in facial nerve palsy after chemotherapy Daphine Caxias Travassos, Heitor Albergoni Silveira, Evânio Vilela Silva, Beatriz Zamboni Martins Panucci, Nilson Coelho da Silva Filho, Paula Verona Ragusa Silva, Andreia Bufalino, Jorge Esquiche León Journal of Cutaneous Pathology.2022; 49(6): 560. CrossRef
A Study of Antimicrobial Activity of Herbal Extracts on Clostridium difficile Eunhak Seong, Sookyoung Lim, Myeongjong Lee, Hojun Kim Journal of Korean Medicine Rehabilitation.2021; 31(1): 47. CrossRef
Rare case of CD8+ CD56+ cytotoxic variant of mycosis fungoides clinically presenting with a combination of hypopigmentation and poikiloderma Min‐Young Park, Shinwon Hwang, Jemin Kim, Abdurrahman I. Almurayshid, Sun Och Yoon, Sang Ho Oh International Journal of Dermatology.2020;[Epub] CrossRef
Mycosis fungoides in Taiwan shows a relatively high frequency of large cell transformation and CD56 expression Ren Ching Wang, Seiji Sakata, Bo-Jung Chen, Sheng-Tsung Chang, Pin-Pen Hsieh, Chi-Shun Yang, Satoko Baba, Kengo Takeuchi, Shih-Sung Chuang Pathology.2018; 50(7): 718. CrossRef
CD8 + mycosis fungoides: A low-grade lymphoproliferative disorder Maria Estela Martinez-Escala, Robert W. Kantor, Ahuva Cices, Xiaolong A. Zhou, Jason B. Kaplan, Barbara Pro, Jaehyuk Choi, Joan Guitart Journal of the American Academy of Dermatology.2017; 77(3): 489. CrossRef
Phenotypic Variation in Different Lesions of Mycosis Fungoides Biopsied Within a Short Period of Time From the Same Patient Natalie Kash, Cesare Massone, Regina Fink-Puches, Lorenzo Cerroni The American Journal of Dermatopathology.2016; 38(7): 541. CrossRef
We present a case of a 44 year-old man with histiocytic sarcoma arising from the rectum. Histiocytic sarcoma is a rare type of malignant lymphoma, comprising less than 0.5% of all non-Hodgkin's lymphomas (NHLs). In this case, the tumor was a polypoid mass, measuring 2.5 x 2 cm. On microscopic examination, it was composed of many bizarre multinucleated cells and sheets of xanthomatous histiocytes.
There were also areas with spindle cells arranged in a storiform pattern. Extensive metastases to regional lymph nodes were found, and combined adjuvant chemotherapy was administered after complete resection.
BACKGROUND Panax ginseng is known to decrease the 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD)-induced testicular toxicity. Thus, we aimed to reveal the differences between Panax ginseng and Panax quinquefolium extract for their effects on TCDD-induced toxicity. METHODS Forty rats were divided into four groups; the control group, the TCDD only group, the TCDD plus Panax ginseng group, and the TCDD plus Panax quinquefolium-treated groups. Ginseng extract was given orally to rats from day one to twenty-one. TCDD was intraperitoneally administered to rats at a single dose of 50 microgram/kg on the seventh day. The pathologic changes were then examined. The changes of body weight, cholesterol and GOT in the serum were also examined. RESULTS The TCDD toxicity was prominent in the thymus, liver and testis. The thymus showed atrophy and an inverse pattern of lymphocyte density in the cortex and medulla. The liver revealed central necrosis with fatty changes. On electron microscopy, the seminiferous tubules showed destruction of the spermatogonia, clear spaces or vacuolar changes and degeneration in the Sertoli cells or germ cells.
The above mentioned TCDD-induced changes were reduced in the rats that were administered with Panax ginseng, whereas Panax quinquefolium did not reduce these changes. CONCLUSION The protective effects of Panax ginseng on the TCDD-induced toxicity were more effective than those of Panax quinquefolium.
BACKGROUND The expressions of galectin-3, cytokeratin 19, p53, and Ki-67 in papillary carcinoma (PC), follicular carcinoma (FC), follicular adenoma (FA), and nodular hyperplasia (NH) are characteristic for the differential diagnosis between benign and malignant thyroid tumors. METHODS The expressions of the four markers were evaluated in PC (n=37), FC (n=12), FA (n=22), and NH (n=23) by immunohistochemical staining. RESULTS Statistical analyses revealed that galectin-3 was significantly expressed in the malignant tumor cells of PC and FC, while CK19 was expressed only in PC. CONCLUSION These results show that galectin-3 is useful in differential diagnosis between malignant and benign thyroid lesions, especially between FC and FA in the patients over 20 years old, and indicate that CK19 is valuable in differentiating between follicular variant of PC and FC and between PC and papillary area of nodular hyperplasia.
BACKGROUND Although the genetic determinants of most sporadic breast cancers remain unknown, the understanding of the molecular and genetic events that contribute to breast carcinogenesis has been significantly advanced. We investigated the clinicopathologic significance of allelic imbalance or mutation of both p53 and PTEN tumor suppressor genes in sporadic breast carcinomas. METHODS Genomic DNA from 62 breast carcinoma cases was extracted from paraffin blocks, and PCR was performed to determine loss of heterozygosity (LOH) for DNA markers around the p53 and PTEN genes and to amplify exons 5, 6, 7, and 8 of p53 and all 9 coding axons of PTEN. RESULTS Somatic p53 mutations were detected in 6 (9.7%) of the 62 cases. LOH for DNA markers surrounding p53 was observed in 18 (29.0%) of the 62 cases. LOH for DNA markers surrounding PTEN was detected in 29 (46.8%) of the 62 cases.
Only one case (1.6%) showed somatic PTEN mutations. Tumors with LOH on 17p or p53 mutation were large in size and negative for ER, had a high Ki-67 index, and exhibited p53 immunoreactivity (p<0.05). Tumors with LOH on 10q23 were associated with c-erbB-2 positivity (p=0.018). CONCLUSIONS Our results indicate that LOH at 17p and/or p53 mutation is significantly associated with the aggressive pathologic parameters of breast cancer.
Paratesticular papillary serous tumors have been rarely reported, and they often resemble ovarian serous tumors of borderline malignancy. We experienced a case of papillary serous tumor in the left paratestis of a 39-year-old man.
This is the second case reported in the Korean literature.
The tumor, which was found incidentally during an operation for a hydrocele, was composed of papillary structures lined by cuboidal to columnar epithelial cells that displayed low cytologic atypia and frequent psammoma bodies.
Three patients with primary non-Hodgkin's lymphoma of the uterine cervix are reported and the literature is reviewed.
All the three patients in the current study presented with vaginal bleeding. They were found to have diffuse large cleaved cell lymphoma, one of which was multilobated variant with marked sclerosis. Histologically, differential diagnsis from undifferentiated small cell carcinoma, endometrial stromal sarcoma & other sarcomas was difficult and requires special stains including immunobistochemical study. Vaginal pap smears were diagnosed as 'class V; malignant lymphoma' in only one patient. Immunologically, two cases were beta-cell lineage and one case was T-cell lineage. All the patients were treated with chemotherapy only and showed good responses.